Novavax looks to next flu vaccine trial following sale of manufacturing business

Washington Business Journal

Aug 7, 2019

Novavax Inc. has the green light to start a late-stage clinical trial for its seasonal flu vaccine, less than six months after a phase 3 trial for its respiratory syncytial virus v…